Close Menu

NEW YORK — NuProbe said on Thursday that it has granted a worldwide license for its proprietary blocker displacement amplification (BDA) technology to Oxford Nanopore Technologies.

Financial terms of the deal were not disclosed.

According to NuProbe, the BDA technology selectively amplifies low-abundance sequence variants in a background of wildtype DNA and can be combined with nanopore sequencing to enable greater detection sensitivities and quantification of somatic mutations at less than 5 percent allele frequency.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

Dec
10
Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.